Metallothionein acts as a cytoprotectant against doxorubicin toxicity

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 1, 2000, Pages 299-302

  Kimura, Tomoki ^a   Fujita, Isami ^a   Itoh, Norio ^a   Muto, Norio ^b   Nakanishi, Tsuyoshi ^a   Takahashi, Kyoko ^a   Azuma, Junichi ^a   Tanaka, Keiichi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATINE KINASE; DOXORUBICIN; HEXANE; LACTATE DEHYDROGENASE; ZINC;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOTOXICITY; CELL PROTECTION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ANIMALS; CELLS, CULTURED; CREATINE KINASE; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG INTERACTIONS; HEART; L-LACTATE DEHYDROGENASE; LIVER; MALE; METALLOTHIONEIN; MICE; MICE, INBRED ICR; TIME FACTORS; ZINC;

EID: 0033962060     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Anne V (1983) Lactate dehydrogenase, in Methods of Enzymatic Analysis (Jurgen B and Marianne G eds) vol III, pp 118-133, Verlag Chemie, Weinheim.
2. Bachur NR, Gordon SL and Gee MW (1978) A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res 38:1745-1750.
3. DiSilvestro RA and Joseph E (1995) An acute phase response does not elevate rat heart metallothionein levels, nor inhibit adriamycin toxicity. Res Commun Mol Pathol Pharmacol 88:107-114.
4. DiSilvestro RA Liu J and Klaassen CD (1996) Transgenic mice overexpressing metallothionein are not resistant to adriamycin cardiotoxicity. Res Commun Mol Pathol Pharmacol 93:163-170.
5. Doroshow JH, Locker GY, Ifrim I and Myers CE (1981) Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. J Clin Invest 68:1053-1064.
6. Eaton DL and Toal BF (1982) Evaluation of the Cd/hemoglobin affinity assay for the rapid determination of metallothionein in biological tissues. Toxicol Appl Pharmacol 66:134-142.
7. Ganey PE, Kauffman FC and Thurman RG (1988) Oxygen-dependent hepatotoxicity due to doxorubicin: role of reducing. Mol Pharmacol 34:695-701.
8. Hamer DH (1986) Metallothionein. Annu Rev Biochem 55:913-951.
9. Iszard MB, Liu J and Klaassen CD (1995) Effect of several metallothionein inducers on oxidative stress defense mechanisms in rats. Toxicology 104:25-33.
10. Itoh N, Kimura T, Nakanishi H, Muto N, Kobayashi M, Kitagawa I and Tanaka K (1997) Metallothionein-independent hepatoprotection by zinc and sakurasosaponin. Toxicol Lett 93:135-140.
11. Kalyanaraman B, Sealy RC and Sinha BK (1984) An electron spin resonance study of the reduction of peroxides by Anthracycline semiquinones. Biochem Biophys Acta 779:270-275.
12. Kang YJ, Chen Y and Epstein PN (1996) Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J Biol Chem 271: 12610-12616.
13. Kang YJ, Chen Y, Yu A, Voss-McCowan M and Epstein PN (1997) Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J Clin Invest 100:1501-1506.
14. Klaunig JE, Goldblatt PJ, Hinton DE, Lipsky MM, Chacko J and Trump BF (1981) Mouse liver cell culture. I. Hepatocyte isolation. In Vitro 17:913-925.
15. Kondo Y, Woo ES, Michalska AE, Choo KH and Lazo JS (1995) Metallothionein null cells have increased sensitivity to anticancer drugs. Cancer Res 55:2021-2023.
16. Lee V, Randhawa AK and Singal PK (1991) Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals. Am J Physiol 261:H989-H995.
17. Lemkuil DC, Nettesheim D, Shaw CF III and Petering DH (1994) Reaction of Cd7-metallothionein with cis-dichlorodiammine platinum (II). J Biol Chem 269: 24792-24797.
18. Liu J, Liu Y, Habeebu SS and Klaassen CD (1998a) Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity. Toxicol Appl Pharmacol 149:24-31.
19. Liu Y, Hartley DP and Liu J (1998b) Protection against carbon tetrachloride hepatotoxicity by oleanolic acid is not mediated through metallothionein. Toxicol Lett 95:77-85.
20. Masters BA, Kelly EJ, Quaife CJ, Brinster RL and Palmiter RD (1994) Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci USA 91:584-588.
21. Michalska AE and Choo KH (1993) Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc Natl Acad Sci USA 90:8088-8092.
22. Min KS, Terano Y, Onosaka S and Tanaka K (1991) Induction of hepatic metallothionein by nonmetallic compounds associated with acute-phase response in inflammation. Toxicol Appl Pharmacol 111:152-162.
23. Miura T, Muraoka S and Ogiso T (1997) Antioxidant activity of metallothionein compared with reduced glutathione. Life Sci 60:301-309.
24. Morgans H and Robert R (1983) Alanine aminotransferase, in Methods of Enzymatic Analysis (Jurgen B and Marianne G eds) vol III, pp 444-456, Verlag Chemie, Weinheim.
25. Nakagawa I, Nishi E, Naganuma A and Imura N (1995) Effect of preinduction of metallothionein synthesis on clastogenicity of anticancer drugs in mice. Mutat Res 348:37-43.
26. Naganuma A, Satoh M and Imura N (1988) Specific reduction of toxic side effects of adriamycin by induction of metallothionein in mice. Jpn J Cancer Res 79:406-411.
27. Okazaki Y, Miura N, Satoh M, Imura N and Naganuma A (1998) Metallothionein-mediated resistance to multiple drugs can be induced by several anticancer drugs in mice. Biochem Biophys Res Commun 245:815-818.
28. Olson RD and Mushlin PS (1990) Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J 4:3076-3086.
29. Pattanaik A, Bachowski G, Laib J, Lemkuil DJ, Shaw CF III, Petering DH, Hitchcock A and Saryan L (1992) Properties of the reaction of cis-dichlorodiammineplatinum(II) with metallothionein. J Biol Chem 267:16121-16128.
30. 2 with sulfhydryl groups in HL-60 cells: Zinc-metallothionein and other sites. Arch Biochem Biophys 334:241-250.
31. Rofe AM, Barry EF, Shelton TL, Philcox JC and Coyle P (1998) Paracetamol hepatotoxicity in metallothionein-null mice. Toxicology 125:131-140.
32. Saika T, Tsushima T, Ochi J, Akebi N, Nasu Y, Matsumura Y and Ohmori H (1994) Over-expression of metallothionein and drug-resistance in bladder cancer. Int J Urol 1:135-139.
33. Sato M and Bremner I (1993) Oxygen free radicals and metallothionein. Free Radical Biol Med 14:325-337.
34. Satoh M, Aoki Y and Tohyama C (1997a) Protective role of metallothionein in renal toxicity of cisplatinum. Cancer Chemother Pharmacol 40:358-362.
35. Satoh M, Cherian MG, Imura N and Shimizu H (1994) Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis. Cancer Res 54:5255-5257.
36. Satoh M, Naganuma A and Imura N (1988) Involvement of cardiac metallothionein in prevention of adriamycin induced lipid peroxidation in the heart. Toxicology 53:231-237.
37. Satoh M, Nishimura N, Kanayama Y, Naganuma A, Suzuki T and Tohyama C (1997b) Enhanced renal toxicity by inorganic mercury in metallothionein-null mice. J Pharmacol Exp Ther 283:1529-1533.
38. Shan K, Lincoff AM and Young JB (1996) Anthracycline-induced cardiotoxicity. Ann Intern Med 125:47-58.
39. Thornalley PJ and Vasak M (1985) Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim Biophys Acta 827:36-44.
40. Villani F, Galimberti M, Monti E, Piccinini F, Lanza E, Rozza A, Favalli L, Poggi P and Zumino F (1990) Effect of GSH and N-acetylcysteine on in vitro and in vivo cardiac toxicity of doxorubicin. Free Radical Res 11:145-151.
41. Westin G and Schaffner W (1988) A zinc-responsive factor interacts with a metal-regulated enhancer element (MRE) of the mouse metallothionein-I gene. EMBO J 7:3763-3770.
42. Willie G (1983) Creatine kinase, in Methods of Enzymatic Analysis (Jurgen B and Marianne G eds) vol III, pp 508-518, Verlag Chemie, Weinheim.
43. Yoda Y, Nakazawa M, Abe T and Kawakami Z (1986) Prevention of doxorubicin myocardial toxicity by reduced glutathione. Cancer Res 46:251-255.